MGI PHARMA is a recipient of the following recognitions:

• 2006 Minnesota Tekne Established Biotechnology Award Recipient
• 2006 Deloitte Technology Fast 500
• 2005 Minnesota Tekne Award Finalist
• 2005 Deloitte Technology Fast 500
• 2004 Deloitte Technology Fast 50
• The Business Journal's Best Performing Firm (2004)
• The Business Journal's Top Public Companies (2005)
• Frost and Sullivan 2004 Cancer Support Therapies Product of the Year
• 2004 Minnesota Tekne Award Finalist